Gentamicin C1a pentaacetate
CAS: 26098-04-4
Ref. 3D-AG16458
| 1mg | 419.00 € | ||
| 2mg | 668.00 € | ||
| 5mg | 1,242.00 € | ||
| 10mg | 2,182.00 € |
Product Information
- O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1-6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-erythro-hexopyranosyl-(1-4)]-2 -deoxy-D-streptamine pentaacetate saltGentamicin D acetateGentamycin C1a acetate
- <span class="text-smallcaps">D</smallcap>-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-<smallcap>L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</span>-erythro-hexopyranosyl-(1→4)]-2-deoxy-
- Geneticin C<sub>1a</sub>
- Gentamicin C1a
- Gentamicin C<sub>1a</sub>
- Gentamicin C<sub>3</sub>
- Gentamycin C<sub>1a</sub>
- O-3-Deoxy-4-C-methyl-3-(methylamino)-β-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</smallcap>-erythro-hexopyranosyl-(1→4)]-2-deoxy-<smallcap>D</span>-streptamine
Gentamicin C1a pentaacetate is a prodrug that is converted to gentamicin, its active form, by the enzyme diacetyl reductase. Gentamicin C1a pentaacetate has minimal toxicity and can be used for the treatment of infections caused by gram-positive species. This drug has been shown to be effective against bowel disease and infectious diseases. Gentamicin C1a pentaacetate is enzymatically inactivated by the wild-type strain of Escherichia coli and other gram-negative bacteria. The matrix effect may affect the pharmacokinetics of this drug, which can be studied using an analytical method.
Chemical properties
Technical inquiry about: 3D-AG16458 Gentamicin C1a pentaacetate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
